Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_assertion type Assertion NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_head.
- NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_assertion description "[As previous studies demonstrated both an increase in PGE2 synthesis and an up-regulation of COX-2 and iNOS mRNA by ischemia-reperfusion injury in the model (Braun and Kietzmann, 2004), inhibitory effects of the glucocorticoid dexamethasone, the NSAID flunixin and the selective COX-2 inhibitor DFU (5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2-(5H)-furanone) were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_provenance.
- NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_assertion evidence source_evidence_literature NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_provenance.
- NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_assertion SIO_000772 15057408 NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_provenance.
- NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_assertion wasDerivedFrom befree-20140225 NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_provenance.
- NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_assertion wasGeneratedBy ECO_0000203 NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_provenance.